A Largely Preemptive Strategy for Prevention of Cytomegalovirus (CMV) Disease Less Practical in D+/R- Liver Transplant Recipients Receiving Anti-Thymocyte Globulin (rATG) Than D+/R+ Recipients

Authors :: Belinda Yen-Lieberman
S. Chuang
D. Van Duin
D. Kelly
Jessica Bollinger
Christine E. Koval
Source :: Transplantation. 98:795
Publication Year :: 2014
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2014.

Subjects :: Cytomegalovirus infection
Transplantation
business.industry
Immunology
Congenital cytomegalovirus infection
medicine
medicine.disease
business
Anti-thymocyte globulin

Full Text Access

Tools